Cognitive, Neuro & Sleep
Nootropics, neuroregenerative, sleep and mood-regulating peptides explored in cognitive and neurological research. 20 profiles
BDNF Mimetic Peptides
Generic category of peptides promoted as BDNF mimetics; specific products are not identified in the literature.
Read profile →02Blood-Brain Barrier Peptide Analogs
Catalog name implying peptides that cross or act at the blood-brain barrier; no specific products are defined in the literature.
Read profile →03Central Pain Pathway Modulator Analogs
Umbrella catalog name implying peptides acting on central pain processing; no specific compounds are documented.
Read profile →04Cerebrolysin Peptide Fraction
Pharmaceutical preparation of low-molecular-weight peptides derived from porcine brain, approved in some countries for dementia and stroke recovery.
Read profile →05CNTF Analogs
Category of products sold as CNTF-related peptides; CNTF and its clinical analog Axokine are real, but these items are not documented.
Read profile →06Conolidine
Monoterpene indole alkaloid from Tabernaemontana divaricata studied as a candidate non-opioid analgesic; a small molecule, not a peptide.
Read profile →07Cortagen
Peptide marketed as a brain-related bioregulator; identity and supporting studies could not be confirmed in the literature.
Read profile →08Descending Inhibitory Pathway Modulators
Catalog name implying peptides acting on descending inhibitory pain pathways; no specific products are characterized.
Read profile →09Dihexa
Synthetic small-molecule compound developed in academic research on HGF/c-Met signaling; reported to improve memory in rodent models. Not a peptide.
Read profile →10DL-148 (Mood Peptide Analog)
Vendor designation for a mood peptide analog; no compound with this identifier appears in the literature.
Read profile →11DSIP (Delta Sleep-Inducing Peptide)
Nonapeptide first described in the late 1970s as a sleep-promoting factor; human sleep effects have been inconsistent across published studies.
Read profile →12Dynorphin Analogs
Catalog category of dynorphin-related peptides; dynorphins are real kappa-opioid peptides, but these products are undocumented.
Read profile →13KLOW (Lys-Pro-Val Complex)
Vendor-defined name used inconsistently for KPV or for multi-peptide blends; no peer-reviewed literature on KLOW itself.
Read profile →14NGF Analogs
Catalog heading for products claimed to mimic nerve growth factor; NGF is a large protein, and these analogs lack published identity.
Read profile →15Noopept
Dipeptide-derived nootropic (N-phenylacetyl-L-prolylglycine ethyl ester) developed in Russia; animal literature with limited human trials.
Read profile →16Nootropic Peptide Complex Analogs
Vendor category grouping nootropic peptide products; no fixed composition or published research identity.
Read profile →17Pinealon
A synthetic tripeptide from the Russian bioregulatory-peptide program, studied mainly in animal models for neuroprotective and cognitive effects.
Read profile →18Selank
A tuftsin-related synthetic heptapeptide developed in Russia as an anxiolytic, studied for anxiety-spectrum and cognitive effects.
Read profile →19Semax
A synthetic ACTH(4-10) heptapeptide analog registered in Russia as a nootropic, studied for cognitive and neuroprotective effects.
Read profile →20Sensory Integration Peptide Analogs
A vendor category combining sensory integration with peptide analogs; no such research peptide family exists in the literature.
Read profile →